IPSEN financials
IPSEN
Country: FR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
549300M6SGDPB4Z94P11 Financial statements
(EUR, as reported — unscaled; 114 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | €618.7M | €571.2M |
| Operating profit (EBIT) | €496.7M | €816.0M |
| Income tax expense | €74.9M | €136.2M |
| Profit for the year | €347.3M | €647.2M |
| — attributable to owners | €345.9M | €644.4M |
| — attributable to NCI | €1.4M | €2.8M |
| Total comprehensive income | €461.2M | €593.6M |
| Per share | ||
| Basic EPS | €4.18 | €7.79 |
| Diluted EPS | €4.15 | €7.73 |
| Cash flow statement | ||
| Net cash from operating activities | €915.5M | €865.9M |
| Net cash from investing activities | -€676.6M | -€1.08B |
| Net cash from financing activities | -€100.0M | -€452.4M |
| Dividends paid | €99.6M | €99.6M |
| Net change in cash | €138.9M | -€664.7M |
| Balance sheet | ||
| Total assets | €6.44B | €6.32B |
| Non-current assets | €4.42B | €4.42B |
| Intangible assets & goodwill | €699.5M | €663.9M |
| Current assets | €2.02B | €1.90B |
| Inventories | €285.5M | €289.5M |
| Trade & other receivables | €697.2M | €631.3M |
| Cash & equivalents | €678.1M | €528.4M |
| Total equity | €4.18B | €3.82B |
| — attributable to owners | €4.18B | €3.83B |
| Non-controlling interests | €200.0K | -€1.3M |
| Non-current liabilities | €751.7M | €872.2M |
| Current liabilities | €1.51B | €1.63B |
| Deferred tax liabilities | €55.2M | €226.4M |
| Derived metrics | ||
| Operating margin | 13.9% | 24.7% |
| Net margin | 9.7% | 19.6% |
| Return on equity | 8.3% | 16.9% |
| Cash conversion ratio | 2.64× | 1.34× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€20.0M | -€8.9M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€45.3M | -€1.6M |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | -€1.9M | -€700.0K |
| Adjustments For Income Tax Expense | €80.1M | €117.8M |
| Adjustments For Increase Decrease In Trade Account Payable | €58.8M | €109.5M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€82.1M | €16.6M |
| Adjustments For Sharebased Payments | €29.5M | €30.1M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €500.0K | -€5.4M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €0 | €21.1M |
| Bank Overdrafts Classified As Cash Equivalents | €600.0K | €9.0M |
| Basic Earnings Loss Per Share From Continuing Operations | €4.30 | €7.46 |
| Basic Earnings Loss Per Share From Discontinued Operations | €-0.12 | €0.33 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €677.6M | €519.5M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €1.14B | €1.01B |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.5M | €2.8M |
| Comprehensive Income Attributable To Owners of Parent | €459.7M | €590.8M |
| Comprehensive Income From Continuing Operations | €471.2M | €566.3M |
| Comprehensive Income From Discontinued Operations | -€10.0M | €27.3M |
| Current Provisions | €47.5M | €56.8M |
| Current Tax Assets Current | €58.9M | €106.2M |
| Current Tax Liabilities Current | €24.9M | €41.4M |
| Deferred Tax Assets | €284.7M | €324.8M |
| Diluted Earnings Loss Per Share From Continuing Operations | €4.27 | €7.40 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €-0.12 | €0.33 |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €99.6M | €99.6M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.40 | — |
| Dividends Recognised As Distributions To Owners Per Share | €1.20 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €19.2M | €5.0M |
| Equity and Liabilities | €6.44B | €6.32B |
| Expense of Restructuring Activities | €14.1M | €27.7M |
| General and Administrative Expense | €216.3M | €217.8M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €280.9M | -€253.4M |
| Income Tax Relating To Components of Other Comprehensive Income | -€7.3M | -€3.3M |
| Income Taxes Paid Refund Classified As Operating Activities | €173.9M | €216.3M |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | €0 | €13.6M |
| Increase Decrease In Working Capital | €54.5M | -€76.1M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €29.5M | €30.1M |
| Increase Decrease Through Transfers and Other Changes Equity | €600.0K | -€700.0K |
| Increase Decrease Through Treasury Share Transactions | -€33.7M | -€39.5M |
| Intangible Assets Other Than Goodwill | €2.52B | €2.68B |
| Interest Paid Classified As Financing Activities | €8.2M | €22.6M |
| Interest Revenue Expense | -€8.6M | -€19.4M |
| Investment Accounted For Using Equity Method | €17.3M | €16.7M |
| Issued Capital | €83.8M | €83.8M |
| Miscellaneous Other Operating Expense | €424.7M | €453.3M |
| Miscellaneous Other Operating Income | €120.6M | €62.6M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €157.9M | €114.7M |
| Noncurrent Provisions For Employee Benefits | €24.2M | €24.4M |
| Other Adjustments For Noncash Items | €43.2M | €87.3M |
| Other Comprehensive Income | €113.9M | -€53.6M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €141.0M | -€55.8M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€4.3M | €10.4M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €2.4M | -€3.2M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €115.9M | -€60.9M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€2.0M | €7.2M |
| Other Current Assets | €293.1M | €332.3M |
| Other Current Financial Assets | €8.5M | €10.6M |
| Other Current Liabilities | €427.9M | €623.2M |
| Other Finance Income Cost | -€56.4M | -€35.1M |
| Other Inflows Outflows of Cash Classified As Investing Activities | €14.7M | €1.4M |
| Other Longterm Provisions | €35.7M | €32.8M |
| Other Noncurrent Assets | €75.7M | €50.8M |
| Other Noncurrent Financial Assets | €200.0K | €300.0K |
| Other Noncurrent Liabilities | €243.8M | €247.2M |
| Other Revenue | €173.9M | €178.9M |
| Proceeds From Current Borrowings | €200.0K | €2.60B |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €173.3M | €500.0K |
| Proceeds From Noncurrent Borrowings | €77.0M | €24.9M |
| Profit Loss From Continuing Operations | €357.3M | €619.9M |
| Profit Loss From Discontinued Operations | -€10.0M | €27.3M |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | €65.2M | €5.7M |
| Repayments of Current Borrowings | €31.8M | €2.61B |
| Repayments of Noncurrent Borrowings | €1.2M | €300.7M |
| Research and Development Expense | €686.6M | €619.3M |
| Reserve of Exchange Differences On Translation | €135.8M | -€3.9M |
| Retained Earnings Profit Loss For Reporting Period | €345.9M | €644.4M |
| Revenue From Contracts With Customers | €3.57B | €3.31B |
| Revenue From Sale of Goods | €3.40B | €3.13B |
| Selling Expense | €957.2M | €917.1M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €500.0K | -€5.4M |
| Trade and Other Current Payables To Trade Suppliers | €854.8M | €771.4M |
Methodology
Every line item above is a fact tagged in IPSEN's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.